Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications
|
March 3, 2006
Expression, purification, crystallization and preliminary X-ray analysis of the human RuvB-like protein RuvBL1
Sabine Gorynia, Pedro M Matias, Susana Gonçalves, et al.
The Journal of Biological Chemistry
|
February 6, 2014
Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1
Marie Jung, Martin Philpott, Susanne Müller, et al.
International Journal of Molecular Sciences
|
January 8, 2025
Darolutamide in Combination with Radium-223 Exhibits Synergistic Antitumor Efficacy in LNCaP Prostate Cancer Models
Urs B Hagemann, Christoph A Schatz, Mari I Suominen, et al.
International Journal of Molecular Sciences
|
February 11, 2023
Enhanced Antitumor Efficacy of Radium-223 and Enzalutamide in the Intratibial LNCaP Prostate Cancer Model
Mari I Suominen, Matias Knuuttila, Christoph A Schatz, et al.
Oncotarget
|
May 4, 2018
BET inhibition is an effective approach against KRAS-driven PDAC and NSCLC
Toni Jauset, Daniel Massó-Vallés, Sandra Martínez-Martín, et al.
Journal of Medicinal Chemistry
|
May 15, 2015
Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF
James Bennett, Oleg Fedorov, Cynthia Tallant, et al.
Cancers
|
January 18, 2020
Characterization of the Menin-MLL Interaction as Therapeutic Cancer Target
Krzysztof Brzezinka, Ekaterina Nevedomskaya, Ralf Lesche, et al.
Oncotarget
|
January 14, 2016
BAY 1024767 blocks androgen receptor mutants found in castration-resistant prostate cancer patients
Tatsuo Sugawara, Pascale Lejeune, Silke Köhr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 26, 2021
Darolutamide Potentiates the Antitumor Efficacy of a PSMA-targeted Thorium-227 Conjugate by a Dual Mode of Action in Prostate Cancer Models
Stefanie Hammer, Andreas Schlicker, Sabine Zitzmann-Kolbe, et al.
Nature Medicine
|
September 19, 2018
Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4
Francesca Zanconato, Giusy Battilana, Mattia Forcato, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications
|
March 3, 2006
Expression, purification, crystallization and preliminary X-ray analysis of the human RuvB-like protein RuvBL1
Sabine Gorynia, Pedro M Matias, Susana Gonçalves, et al.
The Journal of Biological Chemistry
|
February 6, 2014
Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1
Marie Jung, Martin Philpott, Susanne Müller, et al.
International Journal of Molecular Sciences
|
January 8, 2025
Darolutamide in Combination with Radium-223 Exhibits Synergistic Antitumor Efficacy in LNCaP Prostate Cancer Models
Urs B Hagemann, Christoph A Schatz, Mari I Suominen, et al.
International Journal of Molecular Sciences
|
February 11, 2023
Enhanced Antitumor Efficacy of Radium-223 and Enzalutamide in the Intratibial LNCaP Prostate Cancer Model
Mari I Suominen, Matias Knuuttila, Christoph A Schatz, et al.
Oncotarget
|
May 4, 2018
BET inhibition is an effective approach against KRAS-driven PDAC and NSCLC
Toni Jauset, Daniel Massó-Vallés, Sandra Martínez-Martín, et al.
Journal of Medicinal Chemistry
|
May 15, 2015
Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF
James Bennett, Oleg Fedorov, Cynthia Tallant, et al.
Cancers
|
January 18, 2020
Characterization of the Menin-MLL Interaction as Therapeutic Cancer Target
Krzysztof Brzezinka, Ekaterina Nevedomskaya, Ralf Lesche, et al.
Oncotarget
|
January 14, 2016
BAY 1024767 blocks androgen receptor mutants found in castration-resistant prostate cancer patients
Tatsuo Sugawara, Pascale Lejeune, Silke Köhr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 26, 2021
Darolutamide Potentiates the Antitumor Efficacy of a PSMA-targeted Thorium-227 Conjugate by a Dual Mode of Action in Prostate Cancer Models
Stefanie Hammer, Andreas Schlicker, Sabine Zitzmann-Kolbe, et al.
Nature Medicine
|
September 19, 2018
Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4
Francesca Zanconato, Giusy Battilana, Mattia Forcato, et al.
Page
of 6